Ministry advocates for prohibition of exporting tuberculosis medication
Stryker, a leading global medical technology company, is expanding its research and development (R&D) operations in India with a new facility in Bengaluru. The expansion aims to boost Stryker's research and development capabilities in the country, positioning India as a significant player in the global medical industry.
However, the timeline or scale of Stryker's expansion in Bengaluru remains unclear. The new facility will focus on developing innovative medical technologies, contributing to India's growing medical sector.
Meanwhile, a concerning issue has been emerging in the medical world. Lung cancer is being found in patients with tuberculosis, suggesting a potential link between the two diseases. The co-occurrence of these two deadly diseases is costing lives due to delayed diagnoses and treatments. The exact nature of the link between the two diseases is yet to be fully understood, and no specific details were provided about the number of patients affected.
Elsewhere, the Global Grad Show has received entries from 125 universities for projects related to collateral issues of COVID-19. Although no specific institutions have submitted projects about COVID-19 side effects, the initiative underscores the global community's ongoing efforts to address the pandemic's far-reaching impacts.
In a positive development, Dr. L H Hiranandani Hospital in India has received LEED Platinum certification for its commitment to environmentally friendly operations. The certification recognises the hospital's sustainable practices, furthering the industry's shift towards eco-friendly healthcare solutions.
Lastly, the Union Government has directed West Bengal to allow Central Teams to work without obstruction. The directive underscores the government's commitment to ensuring smooth functioning of essential services during these challenging times.
